Cite
Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma
MLA
Michael Mørk Petersen, et al. “Preclinical Development of Tumor-Infiltrating Lymphocyte (TIL) Based Adoptive Cell Transfer (ACT) Immunotherapy for Patients with Sarcoma.” Annals of Oncology, vol. 27, Oct. 2016, p. vi374. EBSCOhost, https://doi.org/10.1093/annonc/mdw378.48.
APA
Michael Mørk Petersen, Anand C. Loya, Anders Krarup-Hansen, M. Nielsen, Dorrit Hovgaard, I.M. Svane, & Niels Junker. (2016). Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma. Annals of Oncology, 27, vi374. https://doi.org/10.1093/annonc/mdw378.48
Chicago
Michael Mørk Petersen, Anand C. Loya, Anders Krarup-Hansen, M. Nielsen, Dorrit Hovgaard, I.M. Svane, and Niels Junker. 2016. “Preclinical Development of Tumor-Infiltrating Lymphocyte (TIL) Based Adoptive Cell Transfer (ACT) Immunotherapy for Patients with Sarcoma.” Annals of Oncology 27 (October): vi374. doi:10.1093/annonc/mdw378.48.